Alahopcin, a new dipeptide antibiotic produced by Streptomyces albulus subsp. ochragerus subsp. nov.

An actinomycete strain No. B-52653 was found to produce an antibiotic selectively active against the in vitro antibiotic resistant mutant of Staphylococcus aureus. Based on taxonomic studies, the name Streptomyces albulus subsp. ochragerus subsp. nov. is proposed for the strain. The microorganism produced two kinds of antibiotics; one identical with gougerotin, the other an amphoteric water soluble dipeptide containing L-alanine. The latter has the molecular formula C9H15N3O6 and is named alahopcin. It has a broad antibacterial spectrum and a synergistic effect with some other antibiotics against some antibiotic resistant staphylococci. Alahopcin has a low toxicity and was effective against experimental infections in mice caused by Staphylococcus aureus.
AuthorsE Higashide, S Horii, H Ono, N Mizokami, T Yamazaki, M Shibata, M Yoneda
JournalThe Journal of antibiotics (J Antibiot (Tokyo)) Vol. 38 Issue 3 Pg. 285-95 (Mar 1985) ISSN: 0021-8820 [Print] JAPAN
PMID3839222 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Dipeptides
  • Peptides
  • alahopcin
  • Animals
  • Anti-Bacterial Agents (isolation & purification, pharmacology)
  • Bacteria (drug effects)
  • Chemical Phenomena
  • Chemistry
  • Dipeptides (isolation & purification, pharmacology)
  • Fermentation
  • Male
  • Mice
  • Mice, Inbred ICR
  • Peptides
  • Streptomyces (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: